Phillip Dauwe
Plastic Surgery · Dallas, TXNPI 1699090431
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by AbbVie at 56.0% of the total. Reporting peaked in 2022 at $9,031 and has fallen 86.3% since, to $1,238 in 2025.
Across 242 payments — averaging $70.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- Sientra, Inc.$4K
- Revance Therapeutics, Inc.$1K
- Galderma Laboratories, L.p.$854
- Heron Therapeutics, Inc.$310
- Mentor Worldwide LLC$234
- plus $575 from 9 others
What the payments were for
- Consulting fees$3,00018%
- Speaking & faculty fees$5,00029%
- Travel & lodging$620%
- Food & beverage$6,86240%
- Education$70%
- Gifts$2,05412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 116 | $9,512 |
| Sientra, Inc. | 21 | $4,325 |
| Revance Therapeutics, Inc. | 26 | $1,175 |
| Galderma Laboratories, L.p. | 50 | $854 |
| Heron Therapeutics, Inc. | 5 | $310 |
| Mentor Worldwide LLC | 8 | $234 |
| Musculoskeletal Transplant Foundation Inc. | 5 | $158 |
| Davol Inc. | 1 | $127 |
| Motiva USA, LLC | 1 | $98 |
| Pacira Pharmaceuticals Incorporated | 3 | $56 |
| Johnson & Johnson | 2 | $43 |
| KCI USA, Inc. | 1 | $32 |
| Medtronic | 1 | $27 |
| Merz North America, Inc. | 1 | $24 |
| TELA Bio, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,985 in reported general payments places this provider in the 85th percentile of 337 plastic surgery providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 21 | $192 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $141 |
| Cephalexin | 17 | $46 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Dallas
- Rodney RohrichDallas$388K
- John TebbettsDallas$92K
- James SmarttDallas$91K
- Sameer JejurikarDallas$41K
- James ThorntonDallas$30K
- Jessica BilligDallas$26K
- Frederick DuffyDallas$24K
- Kent HughesDallas$24K
- Douglas SammerDallas$21K
- Jonathan NathanDallas$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.